The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.
Related Posts
William Langewiesche, the ‘Steve McQueen of Journalism,’ Dies at 70
He was a master of long form narratives, often involving high-stakes topics. He reported for Vanity Fair, The Atlantic and The New York Times Magazine.
How Trump Cuts Could Change Your Summer Hiking Trip
The Bureau of Land Management, the Forest Service and the Fish & Wildlife Service manage more public lands than the Parks Service. And their staffs […]
Why Germany’s Economy, Once a Leader in Europe, Is Now in Crisis
The country is facing a second year of zero growth, with industry leaders gloomy and worried about potential tariffs from President-elect Donald Trump.